Beta Blockers in Cardiovascular Pharmacology
Beta blockers are a class of cardiovascular drugs that competitively block beta-adrenergic receptors, preventing sympathetic nervous system agonists (e.g., adrenaline) from binding and triggering their downstream intracellular effects. By antagonizing this receptor-mediated signaling, beta blockers reduce heart rate, contractility, and blood pressure, thereby lowering myocardial oxygen demand and counteracting the effects of the sympathetic ("fight-or-flight") branch of the autonomic nervous system relative to the parasympathetic branch. This mechanism situates beta blockers within cardiovascular pharmacology as agents that modulate the autonomic regulation of cardiac and vascular physiology, with receptor subtype selectivity (β1, β2, β3) determining differential effects on heart, lung, and vascular tissue.